Top 20 global biopharma firms see 1.7 per cent market cap growth to $3.7 billion in 2024 amid policy challenges Read more
Intra-Cellular Therapies acquisition will expand J&J’s presence in neurology space, says GlobalData Read more
Diagnosed prevalent cases of HIV across 7MM to reach 2.2 million in 2033, forecasts GlobalData Read more
Cancer therapeutics present strongest innovation pipeline in next five years, says GlobalData Read more